R
Rocket Pharmaceuticals
RCKT
22.200
USD
-2
(-8.26%)
مفتوح الان
حجم التداول
22,987
الربح لكل سهم
0
العائد الربحي
0
P/E
-6
حجم السوق
1,596,626,325
الأخبار
العنوان: Rocket Pharmaceuticals
القطاع: Healthcare
الصناعة: Biotechnology
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.